Bovine Respiratory Disease Treatment Market (Treatment Type - Vaccines, Antibiotics, NSAIDs, and Immunomodulators; Disease Type - Upper Respiratory Tract Infections, Pneumonia (Lower Respiratory Tract Infection), and Diphtheria; Distribution Channel - Veterinary Hospitals, Veterinary Clinics, Private Veterinary Pharmacies, and Veterinary Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

bovine respiratory disease treatment market

Bovine Respiratory Disease Treatment Market: Snapshot

Lately, there is surge in the demand for beef meat as human population is increasingly relying on beef to meet their protein requirement. However, consumption of beef meat sourced from cattle with bovine respiratory diseases can severely impact the health of human population.

Meanwhile, bovine respiratory disease occurs due to multiple factors. Some of the factors include- shipping, weaning, weather, nutrition, mixing cattle among multiple sources, and respiratory viruses (BRSV, IBR, PI3, and BVD). Usually, the disease occurs frequently in the beef of calves between 70-170 days old, and it is communicable in nature.

The disease is captivating much attention in recent years as it is impacting the beef industry globally. In order to reduce the negative impact of bovine respiratory disease on entire beef industry, effective prevention measures and treatment is required.

Owing to the revenue being spent on bovine disease treatment globally, the bovine respiratory disease treatment market is projected to grow in coming years. As per the research report published by Transparency Market Research, the bovine respiratory disease treatment is likely to advance at a CAGR of 7.6% in between 2016 and 2024. The market value will reach to US$1543.9 mn by 2024.

Pulmonary Care and Preventive Measures Fuelling Advancement in Treatment Procedures

There are multiple treatment options available for bovine respiratory diseases around the globe. Also, research is going on for the advanced treatment of bovine respiratory disease. This factor is most likely to contribute to the stellar growth of global bovine respiratory disease treatment market.

On the other hand, over the counter medication may cause severe side effects on the affected cattle. As a result of this, the market may experience hindrance in the growth of bovine respiratory disease treatment market. However, ongoing change in pattern the cattle care along with emphasis on pulmonary carry is most likely to fuel the expansion of global bovine respiratory disease treatment market.

On the basis of healthcare center, veterinary hospitals is likely to hold prominence in the expansion of global bovine respiratory disease treatment market. This is because veterinary hospitals have various treatment provision and procedures can be carried out easily under one roof. Veterinary clinics allow one-to-one attention, hence, provides extensive procedure options for the treatment of bovine respiratory diseases. Further, veterinary pharmacies have substantial growth potential owing to the rising demand for drugs for both prevention and treatment of bovine disease. This segment is likely to grow steadily in global bovine respiratory disease treatment market.

Inclination Towards Consumption of Meat Demanding Better Treatment Options

 North America has major share in the growth of global bovine respiratory disease treatment market, wherein the U.S. contributes 90% alone. The bovine respiratory disease treatment market is expanding because of increasing in-house production as well as excess consumption of bovine meat in the region. Also, the U.S. is also into the export business of bovine meat.

In spite of huge number of players in the bovine respiratory disease treatment market, the business landscape is a consolidated one. As a result, there is a high degree of competition in the market. Some of the prominent players in the bovine respiratory disease treatment market space are- Merck & Co., Bayer AG, Boehringer Ingelheim GmbH, Virbac Group, Elanco, Bimeda Animal Health, Zoetis Services LLC, Merial, Vetoquinol, and Ceva.

Bovine Respiratory Disease Treatment Market to Gain Impetus from Increasing Cases of respiratory Disorders

There is flood in the interest for hamburger meat as human populace is progressively depending on meat to meet their protein prerequisite. Be that as it may, utilization of hamburger meat sourced from cows with bovine respiratory illnesses can seriously affect the strength of human populace. Additionally, bovine respiratory infection happens because of numerous elements. A portion of the variables incorporate delivery, weaning, climate, nourishment, blending dairy cattle among different sources, and respiratory infections like BVD, BRSV, IBR, and PI3. Generally, the infection happens often in the hamburger of calves between 70-170 days old, and it is transmittable in nature. The illness is enamoring a lot of consideration as of late as it is affecting the hamburger business around the world. To decrease the adverse consequence of bovine respiratory sickness on whole meat industry, compelling anticipation measures and therapy is required. Attributable to the income being spent on bovine infection treatment internationally, the bovine respiratory illness treatment market is projected to fill in the coming years.

The field of pneumonic medicines has acquired footing across the globe as of late. This factor is projected to get voluminous incomes into the worldwide bovine respiratory infection treatment market in the years to come. Moreover, patients experiencing bovine respiratory illness are at a danger of obtaining a few different sicknesses and issues. This factor has additionally assumed a critical part in the development of the worldwide bovine respiratory sickness therapy market. Additionally, the enormous measures of cash spend on medical care and sickness therapy across the world has likewise given a stimulus to the development of the worldwide bovine respiratory infection therapy market.

There are various treatment alternatives accessible for bovine respiratory illnesses all throughout the planet. Additionally, research is continuing for the high level treatment of bovine respiratory sickness. This factor is destined to add to the heavenly development of worldwide bovine respiratory infection treatment market.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bovine Respiratory Disease Treatment Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Bovine Respiratory Disease Treatment Market Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunity
     4.4. Global Bovine Respiratory Disease Treatment Market Analysis and Forecasts, 2014 – 2024
            4.4.1. Pricing - Actuals and Projections, 2014 – 2024 (US$)
            4.4.2. Market Revenue Projections (US$ Mn)
     4.5. Bovine Respiratory Disease Treatment Market - Global Supply Demand Scenario
     4.6. Porter’s Five Force Analysis
     4.7. Value Chain Analysis
            4.7.1. List of active market participants (suppliers/distributors/manufacturers/vendors)
                     4.7.1.1. Product Manufacturers
                     4.7.1.2. Product Distributors
     4.8. Market Outlook

5. Global Bovine Respiratory Disease Treatment Market Analysis and Forecast, Disease Type
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Size (US$ Mn) Forecast, Disease Type,
                     5.4.1.1. Upper Respiratory Tract Infections
                     5.4.1.2. Diphtheria
                     5.4.1.3. Pneumonia (Lower Respiratory Tract Infection)
     5.5. Product Comparison Matrix
     5.6. Market Attractiveness, Disease Type , 2015

6. Global Bovine Respiratory Disease Treatment Market Analysis and Forecast, Treatment Type
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Size (US$ Mn) Forecast, Treatment Type,
            6.4.1. Vaccines
            6.4.2. Antibiotics
            6.4.3. NSAIDs
            6.4.4. Immunomodulators
            6.4.5. Others
     6.5. Product Comparison Matrix
     6.6. Market Attractiveness, Treatment Type , 2015

7. Global Bovine Respiratory Disease Treatment Market Analysis and Forecast, By Distribution Channel
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Size (US$ Mn) Forecast, By Distribution Channel,
            7.4.1. Veterinary Hospitals
            7.4.2. Veterinary Clinics
            7.4.3. Private Veterinary Pharmacies
            7.4.4. Veterinary Research Institutes
            7.4.5. Others
     7.5. Market Attractiveness, By Distribution Channel, 2015

8. Global Bovine Respiratory Disease Treatment Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market Size (US$ Mn) Forecast By Region
            8.3.1. North America
            8.3.2. Europe
            8.3.3. Asia Pacific
            8.3.4. Latin America
            8.3.5. Middle East and Africa
     8.4. Market Attractiveness By Country/Region

9. North America Bovine Respiratory Disease Treatment Market Analysis and Forecast
     9.1. Key Findings
     9.2. Policies and Regulations
     9.3. Market Size (US$ Mn) Forecast, Disease Type,
            9.3.1. Upper Respiratory Tract Infections
            9.3.2. Diphtheria
            9.3.3. Pneumonia (Lower Respiratory Tract Infection)
     9.4. Market Size (US$ Mn) Forecast, Treatment Type,
            9.4.1. Vaccines
            9.4.2. Antibiotics
            9.4.3. NSAIDs
            9.4.4. Immunomodulators
            9.4.5. Others
     9.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
            9.5.1. Veterinary Hospitals
            9.5.2. Veterinary Clinics
            9.5.3. Private Veterinary Pharmacies
            9.5.4. Veterinary Research Institutes
            9.5.5. Others
     9.6. Market Size (US$ Mn) Forecast, By Country
            9.6.1. US
            9.6.2. Canada
     9.7. Market Attractiveness Analysis 
            9.7.1. By Country
            9.7.2. Disease Type
            9.7.3. By Treatment Type
            9.7.4. By Distribution Channel

10. Europe Bovine Respiratory Disease Treatment Market Analysis and Forecast
     10.1. Key Findings
     10.2. Policies and Regulations
     10.3. Market Size (US$ Mn) Forecast, Disease Type,
            10.3.1. Upper Respiratory Tract Infections
            10.3.2. Diphtheria
            10.3.3. Pneumonia (Lower Respiratory Tract Infection)
     10.4. Market Size (US$ Mn) Forecast, Treatment Type,
            10.4.1. Vaccines
            10.4.2. Antibiotics
            10.4.3. NSAIDs
            10.4.4. Immunomodulators
            10.4.5. Others
     10.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
            10.5.1. Veterinary Hospitals
            10.5.2. Veterinary Clinics
            10.5.3. Private Veterinary Pharmacies
            10.5.4. Veterinary Research Institutes
            10.5.5. Others
     10.6. Market Size (US$ Mn) Forecast, By Country
            10.6.1. Germany
            10.6.2. UK
            10.6.3. Spain
            10.6.4. France
            10.6.5. Italy
            10.6.6. Rest of Europe
     10.7. Market Attractiveness Analysis 
            10.7.1. By Country
            10.7.2. Disease Type
            10.7.3. By Treatment Type
            10.7.4. By Distribution Channel

11. Asia Pacific Bovine Respiratory Disease Treatment Market Analysis and Forecast
     11.1. Key Findings
     11.2. Policies and Regulations
     11.3. Market Size (US$ Mn) Forecast, Disease Type,
            11.3.1. Upper Respiratory Tract Infections
            11.3.2. Diphtheria
            11.3.3. Pneumonia (Lower Respiratory Tract Infection)
     11.4. Market Size (US$ Mn) Forecast, Treatment Type,
            11.4.1. Vaccines
            11.4.2. Antibiotics
            11.4.3. NSAIDs
            11.4.4. Immunomodulators
            11.4.5. Others
     11.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
            11.5.1. Veterinary Hospitals
            11.5.2. Veterinary Clinics
            11.5.3. Private Veterinary Pharmacies
            11.5.4. Veterinary Research Institutes
            11.5.5. Others
     11.6. Market Size (US$ Mn) Forecast, By Country
            11.6.1. India
            11.6.2. China
            11.6.3. Japan
            11.6.4. Australia
            11.6.5. Rest of APAC
     11.7. Market Attractiveness Analysis 
            11.7.1. By Country
            11.7.2. Disease Type
            11.7.3. By Treatment Type
            11.7.4. By Distribution Channel

12. Latin America Bovine Respiratory Disease Treatment Market Analysis and Forecast
     12.1. Key Findings
     12.2. Policies and Regulations
     12.3. Market Size (US$ Mn) Forecast, Disease Type,
            12.3.1. Upper Respiratory Tract Infections
            12.3.2. Diphtheria
            12.3.3. Pneumonia (Lower Respiratory Tract Infection)
     12.4. Market Size (US$ Mn) Forecast, Treatment Type,
            12.4.1. Vaccines
            12.4.2. Antibiotics
            12.4.3. NSAIDs
            12.4.4. Immunomodulators
            12.4.5. Others
     12.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
            12.5.1. Veterinary Hospitals
            12.5.2. Veterinary Clinics
            12.5.3. Private Veterinary Pharmacies
            12.5.4. Veterinary Research Institutes
            12.5.5. Others
     12.6. Market Size (US$ Mn) Forecast, By Country
            12.6.1. Brazil
            12.6.2. Mexico
            12.6.3. Rest of LATAM
     12.7. Market Attractiveness Analysis 
            12.7.1. By Country
            12.7.2. Disease Type
            12.7.3. By Treatment Type
            12.7.4. By Distribution Channel

13. Middle East and Africa Bovine Respiratory Disease Treatment Market Analysis and Forecast
     13.1. Key Findings
     13.2. Policies and Regulations
     13.3. Market Size (US$ Mn) Forecast, Disease Type,
            13.3.1. Upper Respiratory Tract Infections
            13.3.2. Diphtheria
            13.3.3. Pneumonia (Lower Respiratory Tract Infection)
     13.4. Market Size (US$ Mn) Forecast, Treatment Type,
            13.4.1. Vaccines
            13.4.2. Antibiotics
            13.4.3. NSAIDs
            13.4.4. Immunomodulators
            13.4.5. Others
     13.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
            13.5.1. Veterinary Hospitals
            13.5.2. Veterinary Clinics
            13.5.3. Private Veterinary Pharmacies
            13.5.4. Veterinary Research Institutes
            13.5.5. Others
     13.6. Market Size (US$ Mn) Forecast, By Country
            13.6.1. South Africa
            13.6.2. Saudi Arabia
            13.6.3. UAE
            13.6.4. Rest of MEA
     13.7. Market Attractiveness Analysis 
            13.7.1. By Country
            13.7.2. Disease Type
            13.7.3. By Treatment Type
            13.7.4. By Distribution Channel

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)
     14.2. Market Share Analysis By Company (2015)
     14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.3.1. Global Market Players
                     14.3.1.1. Merck & Co., Inc.
                                 14.3.1.1.1. Company Overview
                                 14.3.1.1.2. Financial Overview
                                 14.3.1.1.3. Product Portfolio
                                 14.3.1.1.4. Business Strategies
                                 14.3.1.1.5. Recent Developments 
                     14.3.1.2. Zoetis Services LLC
                                 14.3.1.2.1. Company Overview
                                 14.3.1.2.2. Financial Overview
                                 14.3.1.2.3. Product Portfolio
                                 14.3.1.2.4. Business Strategies
                                 14.3.1.2.5. Recent Developments 
                     14.3.1.3. Bayer AG
                                 14.3.1.3.1. Company Overview
                                 14.3.1.3.2. Financial Overview
                                 14.3.1.3.3. Product Portfolio
                                 14.3.1.3.4. Business Strategies
                                 14.3.1.3.5. Recent Developments 
                     14.3.1.4. Elanco
                                 14.3.1.4.1. Company Overview
                                 14.3.1.4.2. Financial Overview
                                 14.3.1.4.3. Product Portfolio
                                 14.3.1.4.4. Business Strategies
                                 14.3.1.4.5. Recent Developments 
                     14.3.1.5. Merial
                                 14.3.1.5.1. Company Overview
                                 14.3.1.5.2. Financial Overview
                                 14.3.1.5.3. Product Portfolio
                                 14.3.1.5.4. Business Strategies
                                 14.3.1.5.5. Recent Developments 
                     14.3.1.6. Boehringer Ingelheim GmbH
                                 14.3.1.6.1. Company Overview
                                 14.3.1.6.2. Financial Overview
                                 14.3.1.6.3. Product Portfolio
                                 14.3.1.6.4. Business Strategies
                                 14.3.1.6.5. Recent Developments 
                     14.3.1.7. Virbac Group
                                 14.3.1.7.1. Company Overview
                                 14.3.1.7.2. Financial Overview
                                 14.3.1.7.3. Product Portfolio
                                 14.3.1.7.4. Business Strategies
                                 14.3.1.7.5. Recent Developments 
                     14.3.1.8. Ceva
                                 14.3.1.8.1. Company Overview
                                 14.3.1.8.2. Financial Overview
                                 14.3.1.8.3. Product Portfolio
                                 14.3.1.8.4. Business Strategies
                                 14.3.1.8.5. Recent Developments 
                     14.3.1.9. Vetoquinol
                                 14.3.1.9.1. Company Overview
                                 14.3.1.9.2. Financial Overview
                                 14.3.1.9.3. Product Portfolio
                                 14.3.1.9.4. Business Strategies
                                 14.3.1.9.5. Recent Developments 
                     14.3.1.10. Bimeda animal health
                                 14.3.1.10.1. Company Overview
                                 14.3.1.10.2. Financial Overview
                                 14.3.1.10.3. Product Portfolio
                                 14.3.1.10.4. Business Strategies
                                 14.3.1.10.5. Recent Developments 

List of Tables

Table 01: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 02: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 03: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 04: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 05: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 06: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 07: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 08: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 09: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 10: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 11: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 12: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 13: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 14: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 15: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 16: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 17: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 18: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 19: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 20: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 21: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 22: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 23: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 24: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 01: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 02: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 03: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 04: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 05: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 06: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 07: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 08: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 09: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 10: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 11: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 12: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024

List of Figures

Figure 01: Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Bovine Respiratory Disease Treatment Average Price (US$/ Treatment Type) 2014–2024
Figure 03: Market Value Share (%), by Disease Type (2015)
Figure 04: Market Value Share (%), by Treatment Type (2015)
Figure 05: Market Value Share (%), by End-user (2015)
Figure 06: Market Value Share (%), by Region (2015)
Figure 07: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Disease Type, 2015 and 2024
Figure 08: Global Upper Respiratory Tract Infections Market Size (US$ Mn), 2014–2024
Figure 09: Global Diphtheria Market Size (US$ Mn), 2014–2024
Figure 10: Global Pneumonia (lower respiratory tract infection) Market Size (US$ Mn), 2014–2024
Figure 11: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Disease Type, 2015
Figure 12: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Treatment Type, 2015 and 2024
Figure 13: Global Vaccines Market Size (US$ Mn), 2014–2024
Figure 14: Global Antibiotics Market Size (US$ Mn), 2014–2024
Figure 15: Global NSAIDs Market Size (US$ Mn), 2014–2024
Figure 16: Global Immunomodulators Market Size (US$ Mn), 2014–2024
Figure 17: Global Others Market Size (US$ Mn), 2014–2024
Figure 18: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Treatment Type, 2015
Figure 19: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 20: Global Veterinary Hospitals Market Size (US$ Mn), 2014–2024
Figure 21: Global Veterinary Clinics Market Size (US$ Mn), 2014–2024
Figure 22: Global Private Veterinary Pharmacies Market Size (US$ Mn), 2014–2024
Figure 23: Global Veterinary Research Institutes Market Size (US$ Mn), 2014–2024
Figure 24: Global Others Market Size (US$ Mn), 2014–2024
Figure 25: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 26: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Region, 2015 and 2024
Figure 27: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Region, 2015
Figure 28: U.S. Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 29: Canada Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 30: North America Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 31: North America Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 32: North America Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 33: North America Market Attractiveness Analysis, by Country, 2014–2024
Figure 34: Germany Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 35: U.K. Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 36: France Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 37: Spain Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 38: Italy Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 39: Rest of Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 40: Europe Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 41: Europe Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 42: Europe Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 43: Europe Market Attractiveness Analysis, by Country, 2014–2024
Figure 44: Japan Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 45: China Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 46: India Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 47: Australia Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 48: Rest of Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 49: Asia Pacific Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 50: Asia Pacific Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 51: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 52: Asia Pacific Market Attractiveness Analysis, by Country, 2014–2024
Figure 53: Brazil Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 54: Mexico Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 55: Rest of Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 56: Latin America Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 57: Latin America Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 58: Latin America Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 59: Latin America Market Attractiveness Analysis, by Country, 2014–2024
Figure 60: South Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 61: UAE Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 62: Rest of Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 63: Middle East & Africa Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 64: Middle East & Africa Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 65: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 66: Middle East & Africa Market Attractiveness Analysis, by Country, 2014–2024
Figure 01: Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Bovine Respiratory Disease Treatment Average Price (US$/ Treatment Type) 2014–2024
Figure 03: Market Value Share (%), by Disease Type (2015)
Figure 04: Market Value Share (%), by Treatment Type (2015)
Figure 05: Market Value Share (%), by End-user (2015)
Figure 06: Market Value Share (%), by Region (2015)
Figure 07: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Disease Type, 2015 and 2024
Figure 08: Global Upper Respiratory Tract Infections Market Size (US$ Mn), 2014–2024
Figure 09: Global Diphtheria Market Size (US$ Mn), 2014–2024
Figure 10: Global Pneumonia (lower respiratory tract infection) Market Size (US$ Mn), 2014–2024
Figure 11: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Disease Type, 2015
Figure 12: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Treatment Type, 2015 and 2024
Figure 13: Global Vaccines Market Size (US$ Mn), 2014–2024
Figure 14: Global Antibiotics Market Size (US$ Mn), 2014–2024
Figure 15: Global NSAIDs Market Size (US$ Mn), 2014–2024
Figure 16: Global Immunomodulators Market Size (US$ Mn), 2014–2024
Figure 17: Global Others Market Size (US$ Mn), 2014–2024
Figure 18: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Treatment Type, 2015
Figure 19: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 20: Global Veterinary Hospitals Market Size (US$ Mn), 2014–2024
Figure 21: Global Veterinary Clinics Market Size (US$ Mn), 2014–2024
Figure 22: Global Private Veterinary Pharmacies Market Size (US$ Mn), 2014–2024
Figure 23: Global Veterinary Research Institutes Market Size (US$ Mn), 2014–2024
Figure 24: Global Others Market Size (US$ Mn), 2014–2024
Figure 25: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2015

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Bovine Respiratory Disease Treatment Market